Sweet paper on hep B reaction alert Which immunosuppressants are high risk? Who needs antiviral prophylaxis? 1⃣Check surface ag, surface ab, core ab prior to treatment 2⃣PPx for JAKi 3⃣Monitor or Ppx for T-cell depleters 4⃣Monitor others sciencedirect.com/science/articl… #livertwitter

In a new trial, researchers evaluated the efficacy and safety of multiple subcutaneous doses of survodutide, a dual agonist of the glucagon receptor and GLP-1 receptor, in participants with MASH and liver fibrosis. Full trial results: nej.md/4bBXQPF

Exciting! single dose siRNA against PNPLA3 ⬇️⬇️ steatosis in >90% Hispanic cohort NEJM Marco Arrese, MD AASLD ALEH Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD pubmed.ncbi.nlm.nih.gov/39083780/

Our new #cholangiocarcinoma study is out in Journal of Hepatology shorturl.at/GzNw8 @Pank_PW and team created a new mouse model of cholangiocacinoma arising in the PSC-like settings 👇A thread 🧵with key paper highlights 1/8

Los hospitales en los que se hace investigación son aquellos en los que mejor se atiende a los pacientes. Iba a decir aquello de “no tengo pruebas pero tampoco dudas”, pero espera, es que resulta que SI HAY PRUEBAS… 👉 sciencedirect.com/science/articl…

I did not dare to share this link when published this summer out of fear it might be perceived as self-promotion. But it is a beautiful text, so I take the chance. journal-of-hepatology.eu/article/S0168-…

Major academic publishers' revenue and what they pay authors and reviewers: Revenue: Elsevier: $3.9 billion Springer Nature: $2 billion Taylor & Francis: $800M Wiley: $1.8 billion They pay: Academic authors: $0 Peer reviewers: $0

Lewis Roberts starting the Africa HepatoPancreatoBiliary Cancer Consortium conference in Mombasa Very excited about the next few days ! Kirk Wangensteen, MD/PhD Akwi Asombang MD MPH KESHO Jesus Bañales

III Africa HepatoPancreatoBiliary Cancer Consortium meeting! 📍Mombassa, Kenya - Generate knowledge on HCC, CCA & PDAC in 🌍 - Clinical & research training - Biorepository - Genetics - Biomarkers - International collaborations - Support ECIs & beyond! Under Lewis Roberts guidance all good can happen!😉

Be sure to listen to our most recent Living with #PSC podcast! bit.ly/LivingPSCPodca… Niall McKay Tom Hemming Karlsen @PSCaware #livertwitter

Something needs to change in academics. We often pay to get our papers published and spend hours peer reviewing papers for free. And we do it…….for MULTI-MILLION PUBLISHING COMPANIES.

🌍African Network for Hepatitis B Awareness and Education 🎯awareness/education 👉best and cheapest prevention strategy 📲hepB app available 👩‍💻website with all info Africa HepatoPancreatoBiliary Cancer Consortium 👉led by Jose Debes MD PhD 📍Mombasa, Kenya

Functions of #aquaporins beyond water transport. go.nature.com/40Y6Nyj

Great meeting! Friends + Collaborations + Knowledge + Right attitude to fight HPB cancers in Africa! Lewis Roberts Akwi Asombang MD MPH Kirk Wangensteen, MD/PhD Jesus Bañales Africa HepatoPancreatoBiliary Cancer Consortium AORTIC

One-step screening strategy with the OWL liver Panel has high accuracy to detect MASH and at-risk #MASH in high-risk subjects for #MASLD. EASLnews AASLD my_UEG UEGJ Asociación Española para el Estudio del Hígado Sociedad Española de Patología Digestiva (SEPD) onlinelibrary.wiley.com/doi/10.1002/ue…

Are you attending #ESMO24 in #Barcelona? Do not miss this opportunity to interact with Asociación ATUVIBI and other #BiliaryCancer patients advocacy groups Your support would be very much apreciated 🫂 Save the date! 🗓️ 13th Sept - 7pm 😉 Register at: atuvibi.org/evento-confia/

📑 #NASH is the most common indication for LT among the elderly❗️ 1️⃣ Proportion of LT occurring in patients age 65+ years 📈 2️⃣ NASH etiology in more than 1 in 3 listings with ⬆️ prevalence over time #LiverTwitter #MASLD #OpenAccess journals.lww.com/hepcomm/fullte…

Does prognosis differ when one factor drives the MELD score? Yes! Congratulations to Newly minted Hepatologist and top quality human, Craig Rosenstagle, on you Jhep paper doi.org/10.1016/j.jhep…

Te esperamos el próximo 13 de septiembre a las 19h en la Fundació Joan Miró de Barcelona. ¿Te lo vas a perder? 💚 Inscríbete en atuvibi.org/evento-confia/ Angela Lamarca #ATUVIBI #CáncerVíasBiliares #Colangiocarcinoma #Confía #ESMO24

See you there! 🫶 #ESMO24 13th Sept, 7pm Spanish/English speaking event (no language barrier) Asociación ATUVIBI AMMF Cholangiocarcinoma Foundation